Day R - Search Results

1

One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.

Todo S, Fung JJ, Tzakis A, Demetris AJ, Jain A, Alessiani M, Takaya S, Day R, Gordon R, Starzl TE. Todo S, et al. Among authors: day r. Transplant Proc. 1991 Feb;23(1 Pt 2):1397-402. Transplant Proc. 1991. PMID: 1703340

2

Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant.

Jain AB, Todo S, Fung JJ, Venkataramanan R, Day R, Bryant J, Abu-Elmagd KM, Alessiani M, Takaya S, Tzakis A, et al. Jain AB, et al. Among authors: day r. Transplant Proc. 1991 Dec;23(6):3023-5. Transplant Proc. 1991. PMID: 1721347 Free PMC article. Clinical Trial. No abstract available.

3

Cold ischemia time vs outcome of human liver transplantation using UW solution.

Furukawa H, Todo S, Imventarza O, Wu YM, Scotti C, Day R, Starzl TE. Furukawa H, et al. Among authors: day r. Transplant Proc. 1991 Feb;23(1 Pt 2):1550-1. Transplant Proc. 1991. PMID: 1989285 Free PMC article. No abstract available.

4

Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution.

Furukawa H, Todo S, Imventarza O, Casavilla A, Wu YM, Scotti-Foglieni C, Broznick B, Bryant J, Day R, Starzl TE. Furukawa H, et al. Among authors: day r. Transplantation. 1991 May;51(5):1000-4. doi: 10.1097/00007890-199105000-00013. Transplantation. 1991. PMID: 2031256 Free PMC article.

5

A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.

Ernstoff MS, Nair S, Bahnson RR, Miketic LM, Banner B, Gooding W, Day R, Whiteside T, Hakala T, Kirkwood JM. Ernstoff MS, et al. Among authors: day r. J Clin Oncol. 1990 Oct;8(10):1637-49. doi: 10.1200/JCO.1990.8.10.1637. J Clin Oncol. 1990. PMID: 2120392

6

The integration of a novice user interface into a professional modeling tool.

Ramakrishnan S, Hmelo CE, Day RS, Shirey WE, Huang Q. Ramakrishnan S, et al. Among authors: day rs. Proc AMIA Symp. 1998:678-82. Proc AMIA Symp. 1998. PMID: 9929305 Free PMC article.

7

Clinical trial interim monitoring support: requirements and implementation.

Day RS, Davis M. Day RS, et al. AMIA Annu Symp Proc. 2007 Oct 11:926. AMIA Annu Symp Proc. 2007. PMID: 18694026

8

A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis.

Trump DL, Smith DC, Stiff D, Adedoyin A, Day R, Bahnson RR, Hofacker J, Branch RA. Trump DL, et al. Among authors: day r. Cancer Chemother Pharmacol. 1997;39(4):349-56. doi: 10.1007/s002800050582. Cancer Chemother Pharmacol. 1997. PMID: 9025776 Clinical Trial.

9

Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.

Ernstoff MS, Gooding W, Nair S, Bahnson RR, Miketic LM, Banner B, Day R, Whiteside T, Titus-Ernstoff L, Kirkwood JM. Ernstoff MS, et al. Among authors: day r. Cancer Res. 1992 Feb 15;52(4):851-6. Cancer Res. 1992. PMID: 1737346 Clinical Trial.

10

Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer.

Ramalingam S, Belani CP, Day R, Zamboni BA, Jacobs SA, Jett JR. Ramalingam S, et al. Among authors: day r. Ann Oncol. 2004 Feb;15(2):247-51. doi: 10.1093/annonc/mdh061. Ann Oncol. 2004. PMID: 14760117 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,522 results

Search Page

Filters